90321-31-6

Basic information

• Product Name: Benzenesulfonamide, 2-amino-6-methyl- (9CI)
• Synonyms: Benzenesulfonamide, 2-amino-6-methyl- (9CI)
• CAS NO: 90321-31-6
• Molecular Formula: C₇H₁₀N₂O₂S
• Molecular Weight: 186.2315
• Product Categories: SULFONAMIDE
• Mol File: 90321-31-6.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Benzenesulfonamide, 2-amino-6-methyl- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenesulfonamide, 2-amino-6-methyl- (9CI)(90321-31-6)
• EPA Substance Registry System: Benzenesulfonamide, 2-amino-6-methyl- (9CI)(90321-31-6)

Safety Data

• Hazardous Substances Data: 90321-31-6(Hazardous Substances Data)

Upstream product

• 1189-71-5 isocyanate de chlorosulfonyle 
• 108-44-1 1-amino-3-methylbenzene 
• 89-62-3 4-methyl-2-nitroaniline 
• 56202-22-3 2-methyl-6-nitrobenzenesulfonyl chloride 
• 170275-10-2 3-Nitro-toluol-sulfonamid-(2) 

Relevant articles and documents

2,4-DI (PHENYLAMINO) PYRIMIDINES USEFUL IN THE TREATMENT OF PROLIFERATIVE DISORDERS

There is provided a method of preventing or treating proliferative disorders such as a tumor disease, by inhibiting ALK activity with compounds of formula (I) wherein X, R1, R2 , R3 , R4 , R5, R6

4,4-DISUBSTITUTED PIPERIDINE DERIVATIVES HAVING CCR3 ANTAGONISM

The invention provides low molecular compounds having activity which inhibits binding of CCR3 ligands to CCR3 on target cells, i.e. CCR3 antagonists. The invention also provides 4,4-(disubstituted)piperidine derivatives represented by formula (I) below, pharmaceutically acceptable acid adducts thereof, or pharmaceutically acceptable C1-C6 alkyl adducts thereof, as well as pharmaceutical compositions comprising them as effective ingredients, which are useful for treatment or prevention of diseases associated with CCR3, such as asthma and allergic rhinitis.

PIPERIDINE DERIVATIVES HAVING CCR3 ANTAGONISM

The invention provides low molecular compounds having activity which inhibits binding of CCR3 ligands to CCR3 on target cells, i.e. CCR3 antagonists. The invention also provides compounds represented by formula (I) below, pharmaceutically acceptable acid adducts thereof, or pharmaceutically acceptable C1-C6 alkyl adducts thereof, as well as pharmaceutical compositions comprising them as effective ingredients, which are useful for treatment or prevention of diseases associated with CCR3, such as asthma and allergic rhinitis.

Anti-infective agents

Compounds having the formula are hepatitis C (HCV) polymerase inhibitors. Also disclosed are a composition and method for inhibiting hepatitis C (HCV) polymerase, processes for making the compounds, and synthetic intermediates employed in the processes.